[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.108.182. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
June 1988

Preservation of Laryngeal Function in Patients With Carcinoma of the Larynx

Author Affiliations

Ann Arbor, Mich.

Arch Otolaryngol Head Neck Surg. 1988;114(6):621. doi:10.1001/archotol.1988.01860180035025

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

In an effort to preserve laryngeal function in patients with carcinoma of the larynx, Wolf et al reported on a new strategy in treatment at the recent Second International Head and Neck Oncology Research Conference held in Arlington, Va.

In 1985, the Veterans Administration cooperative study program initiated a prospective, randomized multi-institutional study of the effectiveness of induction chemotherapy (CT) and radiation therapy (RT) compared with surgery and postoperative RT in patients with stage III/IV laryngeal squamous carcinoma. Induction CT (cisplatin, 100 mg/m2 administered intravenously on day 1, and fluorouracil, 1000 mg/m2 in a 24-hour infusion on days 1 through 5) was repeated on days 1, 22, and 43. Tumor response was assessed after two cycles; responders received a third cycle followed by tumor biopsy and RT (66 to 76 Gy [6600 to 7600 rad]). Patients having less than a partial response (PR) had salvage laryngectomy and RT.

First Page Preview View Large
First page PDF preview
First page PDF preview
×